Credit Suisse’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $2.26M | Buy |
|
|||||
|
2023
Q4 | $1.06M | Buy |
|
|||||
|
2023
Q3 | $791K | Sell |
|
|||||
|
2023
Q2 | $1.08M | Buy |
|
|||||
|
2023
Q1 | $823K | Buy |
|
|||||
|
2022
Q4 | $835K | Buy |
|
|||||
|
2022
Q3 | $374K | Sell |
|
|||||
|
2022
Q2 | $393K | Buy |
|
|||||
|
2022
Q1 | $473K | Buy |
|
|||||
|
2021
Q4 | $458K | Sell |
|
|||||
|
2021
Q3 | $332K | Buy |
|
|||||
|
2021
Q2 | $356K | Buy |
|
|||||
|
2021
Q1 | $386K | Sell |
|
|||||
|
2020
Q4 | $1.07M | Buy |
|